annual EBIT:
-$50.41M-$4.34M(-9.42%)Summary
- As of today (September 14, 2025), AKBA annual earnings before interest & taxes is -$50.41 million, with the most recent change of -$4.34 million (-9.42%) on December 31, 2024.
- During the last 3 years, AKBA annual EBIT has risen by +$214.09 million (+80.94%).
- AKBA annual EBIT is now -491.53% below its all-time high of -$8.52 million, reached on December 31, 2012.
Performance
AKBA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$14.09M+$575.00K(+4.25%)Summary
- As of today (September 14, 2025), AKBA quarterly earnings before interest & taxes is $14.09 million, with the most recent change of +$575.00 thousand (+4.25%) on June 1, 2025.
- Over the past year, AKBA quarterly EBIT has increased by +$22.81 million (+261.48%).
- AKBA quarterly EBIT is now -71.01% below its all-time high of $48.61 million, reached on June 30, 2022.
Performance
AKBA quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$791.00K+$22.81M(+103.59%)Summary
- As of today (September 14, 2025), AKBA TTM earnings before interest & taxes is $791.00 thousand, with the most recent change of +$22.81 million (+103.59%) on June 1, 2025.
- Over the past year, AKBA TTM EBIT has increased by +$35.89 million (+102.25%).
- AKBA TTM EBIT is now at all-time high.
Performance
AKBA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AKBA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.4% | +261.5% | +102.3% |
| 3 y3 years | +80.9% | -71.0% | +100.6% |
| 5 y5 years | +82.4% | +124.2% | +100.3% |
AKBA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.4% | +80.9% | -71.0% | +128.1% | at high | +100.6% |
| 5 y | 5-year | -9.4% | +82.4% | -71.0% | +116.5% | at high | +100.3% |
| alltime | all time | -491.5% | +82.4% | -71.0% | +114.8% | at high | +100.3% |
AKBA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $14.09M(+4.3%) | $791.00K(-103.6%) |
| Mar 2025 | - | $13.51M(-194.5%) | -$22.02M(-56.3%) |
| Dec 2024 | -$50.41M(+9.4%) | -$14.31M(+14.4%) | -$50.41M(+45.1%) |
| Sep 2024 | - | -$12.51M(+43.3%) | -$34.73M(-1.0%) |
| Jun 2024 | - | -$8.72M(-41.4%) | -$35.10M(-1.0%) |
| Mar 2024 | - | -$14.88M(-1182.8%) | -$35.46M(-23.0%) |
| Dec 2023 | -$46.08M(-28.9%) | $1.37M(-110.7%) | -$46.07M(-18.5%) |
| Sep 2023 | - | -$12.87M(+41.6%) | -$56.56M(-39.8%) |
| Jun 2023 | - | -$9.09M(-64.3%) | -$93.92M(+159.3%) |
| Mar 2023 | - | -$25.49M(+179.7%) | -$36.23M(-47.7%) |
| Dec 2022 | -$64.85M(-75.5%) | -$9.12M(-81.9%) | -$69.23M(-44.8%) |
| Sep 2022 | - | -$50.23M(-203.3%) | -$125.45M(+1.1%) |
| Jun 2022 | - | $48.61M(-183.1%) | -$124.11M(-50.8%) |
| Mar 2022 | - | -$58.49M(-10.5%) | -$252.06M(-2.5%) |
| Dec 2021 | -$264.50M(+1.4%) | -$65.34M(+33.7%) | -$258.50M(-7.2%) |
| Sep 2021 | - | -$48.89M(-38.4%) | -$278.57M(-3.2%) |
| Jun 2021 | - | -$79.34M(+22.2%) | -$287.77M(+7.9%) |
| Mar 2021 | - | -$64.94M(-24.0%) | -$266.73M(+2.2%) |
| Dec 2020 | -$260.92M(-8.9%) | -$85.40M(+47.0%) | -$260.92M(-3.5%) |
| Sep 2020 | - | -$58.09M(-0.3%) | -$270.40M(+0.8%) |
| Jun 2020 | - | -$58.29M(-1.4%) | -$268.21M(-0.5%) |
| Mar 2020 | - | -$59.13M(-37.7%) | -$269.44M(-5.9%) |
| Dec 2019 | -$286.29M(+84.6%) | -$94.89M(+69.7%) | -$286.29M(+1.7%) |
| Sep 2019 | - | -$55.91M(-6.1%) | -$281.53M(+11.1%) |
| Jun 2019 | - | -$59.52M(-21.6%) | -$253.47M(+10.4%) |
| Mar 2019 | - | -$75.97M(-15.7%) | -$229.61M(+28.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$155.06M(+102.2%) | -$90.14M(+223.7%) | -$178.14M(+142.7%) |
| Sep 2018 | - | -$27.84M(-21.9%) | -$73.39M(+5.3%) |
| Jun 2018 | - | -$35.66M(+45.6%) | -$69.73M(+24.1%) |
| Mar 2018 | - | -$24.50M(-267.7%) | -$56.20M(-26.7%) |
| Dec 2017 | -$76.67M(-43.6%) | $14.61M(-160.4%) | -$76.67M(-40.7%) |
| Sep 2017 | - | -$24.18M(+9.2%) | -$129.33M(-8.5%) |
| Jun 2017 | - | -$22.14M(-50.8%) | -$141.33M(-9.0%) |
| Mar 2017 | - | -$44.97M(+18.2%) | -$155.39M(+14.2%) |
| Dec 2016 | -$135.96M(+122.1%) | -$38.04M(+5.1%) | -$136.06M(+15.3%) |
| Sep 2016 | - | -$36.18M(-0.0%) | -$118.01M(+16.3%) |
| Jun 2016 | - | -$36.19M(+41.1%) | -$101.43M(+33.4%) |
| Mar 2016 | - | -$25.65M(+28.3%) | -$76.03M(+24.2%) |
| Dec 2015 | -$61.21M(+63.2%) | -$20.00M(+2.0%) | -$61.21M(+18.1%) |
| Sep 2015 | - | -$19.61M(+81.7%) | -$51.83M(+24.0%) |
| Jun 2015 | - | -$10.79M(-0.3%) | -$41.80M(+7.6%) |
| Mar 2015 | - | -$10.82M(+2.0%) | -$38.85M(+3.3%) |
| Dec 2014 | -$37.50M(+135.3%) | -$10.61M(+10.7%) | -$37.62M(+13.3%) |
| Sep 2014 | - | -$9.58M(+22.2%) | -$33.21M(+20.1%) |
| Jun 2014 | - | -$7.84M(-18.2%) | -$27.66M(+20.6%) |
| Mar 2014 | - | -$9.59M(+54.6%) | -$22.94M(+44.0%) |
| Dec 2013 | -$15.93M(+87.0%) | -$6.20M(+53.7%) | -$15.93M(+37.4%) |
| Sep 2013 | - | -$4.03M(+29.3%) | -$11.60M(+53.3%) |
| Jun 2013 | - | -$3.12M(+21.1%) | -$7.56M(+70.3%) |
| Mar 2013 | - | -$2.58M(+38.2%) | -$4.44M(+138.2%) |
| Dec 2012 | -$8.52M(-45.2%) | - | - |
| Dec 2012 | - | -$1.86M | -$1.86M |
| Dec 2011 | -$15.54M | - | - |
FAQ
- What is Akebia Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual EBIT year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Akebia Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. TTM EBIT year-on-year change?
What is Akebia Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of AKBA is -$50.41M
What is the all time high annual EBIT for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$8.52M
What is Akebia Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, AKBA annual earnings before interest & taxes has changed by -$4.34M (-9.42%)
What is Akebia Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AKBA is $14.09M
What is the all time high quarterly EBIT for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $48.61M
What is Akebia Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, AKBA quarterly earnings before interest & taxes has changed by +$22.81M (+261.48%)
What is Akebia Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AKBA is $791.00K
What is the all time high TTM EBIT for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $791.00K
What is Akebia Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, AKBA TTM earnings before interest & taxes has changed by +$35.89M (+102.25%)